» Articles » PMID: 9520487

Profound Neuronal Plasticity in Response to Inactivation of the Dopamine Transporter

Overview
Specialty Science
Date 1998 May 9
PMID 9520487
Citations 247
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine transporter (DAT) plays an important role in calibrating the duration and intensity of dopamine neurotransmission in the central nervous system. We have used a strain of mice in which the gene for the DAT has been genetically deleted to identify the DAT's homeostatic role. We find that removal of the DAT dramatically prolongs the lifetime (300 times) of extracellular dopamine. Within the time frame of neurotransmission, no other processes besides diffusion can compensate for the lack of the DAT, and the absence of the DAT produces extensive adaptive changes to control dopamine neurotransmission. Despite the absence of a clearance mechanism, dopamine extracellular levels were only 5 times greater than control animals due to a 95% reduction in content and a 75% reduction in release. Paradoxically, dopamine synthesis rates are doubled despite a decrease of 90% in the levels of tyrosine hydroxylase and degradation is markedly enhanced. Thus, the DAT not only controls the duration of extracellular dopamine signals but also plays a critical role in regulating presynaptic dopamine homeostasis. It is interesting to consider that the switch to a dopamine-deficient, but functionally hyperactive, mode of neurotransmission observed in mice lacking the DAT may represent an extreme example of neuronal plasticity resulting from long-term psychostimulant abuse.

Citing Articles

Amphetamine in Adolescence Induces a Sex-Specific Mesolimbic Dopamine Phenotype in the Adult Prefrontal Cortex.

Hernandez G, Zhao J, Niu Z, MacGowan D, Capolicchio T, Song A bioRxiv. 2025; .

PMID: 40060609 PMC: 11888448. DOI: 10.1101/2025.02.26.640363.


Synchrony between midbrain gene transcription and dopamine terminal regulation is modulated by chronic alcohol drinking.

Farahbakhsh Z, Holleran K, Sens J, Fordahl S, Mauterer M, Lopez A Nat Commun. 2025; 16(1):1944.

PMID: 39994195 PMC: 11850823. DOI: 10.1038/s41467-025-56715-y.


Structure of the human dopamine transporter in complex with cocaine.

Nielsen J, Salomon K, Kalenderoglou I, Bargmeyer S, Pape T, Shahsavar A Nature. 2024; 632(8025):678-685.

PMID: 39112703 DOI: 10.1038/s41586-024-07804-3.


An updated review on animal models to study attention-deficit hyperactivity disorder.

Kim D, Yadav D, Song M Transl Psychiatry. 2024; 14(1):187.

PMID: 38605002 PMC: 11009407. DOI: 10.1038/s41398-024-02893-0.


Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function-Not a New Concept, but Neglected Reality.

Salvatore M Int J Mol Sci. 2024; 25(2).

PMID: 38256204 PMC: 10815979. DOI: 10.3390/ijms25021131.


References
1.
Groves P, Linder J, Young S . 5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum. Neuroscience. 1994; 58(3):593-604. DOI: 10.1016/0306-4522(94)90084-1. View

2.
Kopin I . Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev. 1985; 37(4):333-64. View

3.
Roth R, Murrin L, Walters J . Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol. 1976; 36(1):163-71. DOI: 10.1016/0014-2999(76)90268-5. View

4.
Dackis C, Gold M . New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev. 1985; 9(3):469-77. DOI: 10.1016/0149-7634(85)90022-3. View

5.
Kaakkola S, Wurtman R . Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study. Brain Res. 1992; 587(2):241-9. DOI: 10.1016/0006-8993(92)91003-w. View